The corporate governance of the Company is organized under the Belgian Code of Companies and Associations, its articles of association and its governance charter
Board Of Directors
The Board of Directors currently consists of nine members, one of which is an executive director (as a member of the Executive Committee), one being a non-executive director, and six being independent directors, including the Chairman. The directors have been appointed at the Shareholders Meeting of the Company. The Board’s composition reflects a diverse and complementary range of experience, nationalities and cultures, ensuring that the interests of all shareholders are taken into account. Members of the Board of Directors are chosen for their skills, their integrity and their independence of mind.
Michel Lussier, Chairman, Non-Executive Director
Chris Buyse, Independent director
Serge Goblet, Non-executive director
Rudy Dekeyser*, Independent director
Hilde Windels, Independent director
Margo Roberts, Independent director
Filippo Petti, Executive director
Maria Koehler, Independent director
Dominic Piscitelli, Independent director
*permanent representative of R.A.D. Lifesciences BVBA
Committees within the Board of Directors
The Board of Directors may set up specialised committees to analyse specific issues and advise the Board of Directors on those issues.
Such committees are advisory bodies only and the decision-making remains the collegiate responsibility of the Board of Directors.
The Board of Directors has set-up a Nomination and Remuneration Committee. This committee consists of three members; Michel Lussier (Chairman), Chris Buyse and Rudy Dekeyser.
The Board of Directors has set-up an Audit Committee. This committee consists of three members: Chris Buyse (Chairman), Dominic Piscitelli and Hilde Windels.
The Board of Directors of the Company has established an Executive Committee which is an advisory committee to the Board of Directors, under Article 524bis of the BCC. The Executive Committee consists of the "Chief Executive officer" (CEO), who is the chairman of the Executive Committee, the "Vice President Clinical Development & Medical Affaires", the "Chief Scientific Officer", the "Chief Legal Officer", the "Vice President Human Resources" and the "Chief Business Officer".
Filippo Petti, Chief Executive Officer, CFO
Frédéric Lehmann3, VP Medical Affairs and Clinical Development
Stephen Rubino, Chief Business Officer
David Gilham, Chief Scientific Officer
Philippe Dechamps1, Chief Legal Officer
Philippe Nobels2, VP of Human Resources
1. Permanent representative of NandaDevir SRL
2. Permanent representative of MC Consult SRL
3. Permanent representative of ImXsense SRL